SashidharVarmaSagiMDMRCP(UK) FACG

Inflammatory Bowel Disease

Consultant Gastroenterologist

Dr. Sagi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Indiana University School of MedicineFellowship, Gastroenterology, 2010 - 2013
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2007 - 2010
Rangaraya Medical College NTRClass of 1998

PubMed

53 citations
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
Neeraj Narula, Farhad Peerani, Joseph Meserve, Gursimran Kochhar, Khadija Chaudrey
The American Journal of Gastroenterology. 2018-09-01
56 citations
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
Joseph Meserve, Satimai Aniwan, Jenna L. Koliani-Pace, Preeti Shashi, A Weiss
Clinical Gastroenterology and Hepatology. 2019-07-01
22 citations
Association of greater intravenous volume infusion with shorter hospitalization for patients with post-ERCP pancreatitis
Sashidhar Sagi, Suzette E. Schmidt, Evan L. Fogel, Glen A. Lehman, Lee McHenry
Journal of Gastroenterology and Hepatology. 2014-06-01

Journal Articles

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Leah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Gursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature

Why Yearly Vision Exams Are *SO* Important if You Have Crohn’sFebruary 11th, 2020